Visualitzant O - Articles científics per títol

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

Garralda Cabanas, Elena; Eskens, Ferry; Gil-Martin, Marta; Yen, Chia-Jui; Santoro, Armando; Simonelli, Matteo (Elsevier, 2022-10)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

Fuentes Varela, Pedro; Sese Faustino, Marta; Guijarro Carrillo, Pedro Jesus; Emperador Melero, Marta Isabel; Sánchez-Redondo, Sara; Peinado, Héctor; Hümmer, Stefan; Ramon y Cajal Agüeras, Santiago (Nature Research, 2020-08-26)

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

Tabernero Caturla, Josep; Van Cutsem, Eric; Fuchs, Charles; Janjigian, Yelena; Bhagia, Pooja; Bang, Yung-Jue (Future Medicine, 2021-08)

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

Giuliani, Rosa; Tabernero Caturla, Josep; Cardoso, Fatima; McGregor, Keith Hanson; Vyas, Malvika; de Vries, Elisabeth (BMJ, 2019-03-06)

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

Garcia-Casado, Zaida; Oaknin Benzaquen, Ana Mazaltob; Mendiola, Marta; Alkorta-Aranburu, Gorka; Antunez-Lopez, Jose Ramon; Moreno-Bueno, Gema (MDPI, 2022-11-04)

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy A Systematic Literature Review

Macarulla Mercadé, Teresa; Hendifar, Andrew E.; Reni, Michele; Riess, Hanno; Tempero, Margaret A.; Li, Chung-Pin (Wolters Kluwer Health, 2020-03)

Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

Salem, Mohamed E.; El-Refai, Sherif M.; Sha, Wei; Puccini, Alberto; Grothey, Axel; George, Thomas J.; Tabernero Caturla, Josep (American Society of Clinical Oncology, 2022-03-23)

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Naderi, Elnaz; Schack, Line Meinertz Hybel; Dorling, Leila; Rattay, Tim; Ramos Albiac, Monica; Aguado-Barrera, Miguel E; Fachal, Laura; Altabas González, Manuel; Gutiérrez-Enríquez, Sara; Molla, Meritxell; Reyes López, Victoria; Giraldo Marin, Alexandra (Oxford University Press, 2023-12)

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Taylor, Matthew H.; Aghajanian, Carol; Mier, James; Cohn, Allen L.; Makker, Vicky; OAKNIN, ANA (American Society of Clinical Oncology, 2020-09-10)

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Le Rhun, Emilie; Weller, Michael; van den Bent, Martin; Brandsma, D.; Furtner, Julia; RUDA', Roberta; Seoane, Joan (Elsevier, 2023-10)

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

Wirth, Lori J.; Brose, Marcia S; Hoff, Ana; Hu, Mimi; Capdevila Castillon, Jaume; Elisei, Rossella (Future Medicine, 2022-09)

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Pascual García, Mónica; Bonfill Teixidor, Ester; Planas Rigol, Ester; Rubio-Perez, Carlota; Iurlaro, Raffaella; Arias Piñeiro, Alexandra; Cuartas Maza, Ma Isabel; Sala Hojman, Ada; Escudero Monreal, Laura; Martínez Ricarte, Francisco Ramón; Huber Ruano, Isabel; Nuciforo, Paolo Giovanni; Braña Garcia, Irene; Garralda Cabanas, Elena; Vieito Villar, Maria; Espejo Ruiz, Carmen; Sahuquillo Barris, Joan; Tabernero Caturla, Josep; Seoane Suarez, Joan (Nature Research, 2019-06-11)

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

Macarulla Mercadé, Teresa; Chen, Li-Tzong; Siveke, Jens T.; Bodoky, György; Li, Chung-Pin; Cunningham, David (Wolters Kluwer Health, 2020-01)

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial

Macarulla Mercadé, Teresa; Blanc, Jean-Frédéric; Wang-Gillam, Andrea; Chen, Li-Tzong; Siveke, Jens T.; Mirakhur, Beloo (Elsevier, 2019-05-01)

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis

Vidal, Laura; Fabregat Franco, Carles; Castet, Florian; Sierra, Alexandre; Balsells Valls, Joaquin; Pando, Elizabeth; Macarulla, Teresa; Charco, Ramon; Vivancos, Ana; Blanco Cuso, Laia (Elsevier, 2023-08-06)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy A Systematic Literature Review

Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Liver transplantation in metastatic colorectal cancer: are we ready for it?

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

Long-term follow-up of recovered MPN patients with COVID-19

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study ﻿

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells ﻿

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma ﻿

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology ﻿

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study ﻿

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy A Systematic Literature Review ﻿

Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers ﻿

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types ﻿

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer ﻿

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ﻿

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer ﻿

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy ﻿

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial ﻿

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial ﻿

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis ﻿

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy ﻿

Liver transplantation in metastatic colorectal cancer: are we ready for it? ﻿

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib ﻿

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient ﻿

Long-term follow-up of recovered MPN patients with COVID-19 ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy A Systematic Literature Review

Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Liver transplantation in metastatic colorectal cancer: are we ready for it?

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

Long-term follow-up of recovered MPN patients with COVID-19